Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound: A First Case Report
DOI:
https://doi.org/10.2340/actadv.v106.adv-2025-0261Keywords:
epidermolysis bullosa, skin imaging, subepidermal low-echogenic band, mechanobullous diseasesDownloads
References
Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine JD, Harper N, Has C, et al. Epidermolysis bullosa. Nat Rev Dis Primers 2020; 6: 78. DOI: https://doi.org/10.1038/s41572-020-0210-0
Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol 2020; 183: 614–627. DOI: https://doi.org/10.1111/bjd.18921
Mellerio JE. Infection and colonization in epidermolysis bullosa. Dermatol Clin 2010; 28: 267–269. DOI: https://doi.org/10.1016/j.det.2010.01.004
Vergilio MM, Monteiro E Silva SA, Jales RM, Leonardi GR. Highfrequency ultrasound as a scientific tool for skin imaging analysis. Exp Dermatol 2021; 30: 897–910. DOI: https://doi.org/10.1111/exd.14363
Polańska A, Dańczak-Pazdrowska A, Silny W, Woźniak A, Maksin K, Jenerowicz D, et al. Comparison between highfrequency ultrasonography (Dermascan C, version 3) and histopathology in atopic dermatitis. Skin Res Technol 2013; 19: 432–437. DOI: https://doi.org/10.1111/srt.12064
6. Polańska A, Silny W, Jenerowicz D, Knioła K, Molińska-Glura M, Dańczak-Pazdrowska A. Monitoring of therapy in atopic dermatitis--observations with the use of high-frequency ultrasonography. Skin Res Technol 2015; 21: 35–40. DOI: https://doi.org/10.1111/srt.12153
Pazdrowski J, Dańczak-Pazdrowska A, Polańska A, Kaźmierska J, Barczak W, Szewczyk M, et al. An ultrasonographic monitoring of skin condition in patients receiving radiotherapy for head and neck cancers. Skin Res Technol 2019; 25: 857–861. DOI: https://doi.org/10.1111/srt.12745
Cisoń H, Jankowska-Konsur A, Białynicki-Birula R. The Evaluation of Skin Infiltration in Mycosis Fungoides/Sézary Syndrome Using the High-Frequency Ultrasonography. J Clin Med 2025; 14: 7143. DOI: https://doi.org/10.3390/jcm14207143
Dini V, Janowska A, Faita F, Panduri S, Benincasa BB, Izzetti R, et al. Ultra-high-frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatment. Skin Res Technol 2021; 27: 277–282. DOI: https://doi.org/10.1111/srt.12942
Wang J, Zhu Q, Li F, Xiao M, Liu J. Clinical, dermoscopic, and ultrasonic monitoring of the response to biologic treatment in patients with moderate-to-severe plaque psoriasis. Front Med 2023; 10: 1162873. DOI: https://doi.org/10.3389/fmed.2023.1162873
Cortex Technology. DermaScan C USB Instruction Manual (Z0300123 UK). Aarhus, Denmark: Cortex Technology; 2023.
Phillips J, Reynolds KJ, Gordon SJ. Dermal thickness and echogenicity using DermaScan C high frequency ultrasound: methodology and reliability testing in people with and without primary lymphoedema. Skin Res Technol 2020; 26: 813–823. DOI: https://doi.org/10.1111/srt.12880
Wallblom K, Schmidtchen A, Puthia M. High-frequency Ultrasound Reveals Epidermal-dermal Structural Alterations in an Experimental Model of Epidermolysis Bullosa. Acta Derm Venereol 2026; accepted.
Guide SV, Gonzalez ME, Bağcı IS, Agostini B, Chen H, Feeney G, et al. Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa. N Engl J Med 2022; 387: 2211–2219. DOI: https://doi.org/10.1056/NEJMoa2206663
Tang JY, Marinkovich MP, Wiss K, McCarthy D, Truesdale A, Chiou AS, et al. Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a twocentre, randomised, open-label, intrapatient-controlled phase 3 trial. Lancet 2025; 406: 163–173. DOI: https://doi.org/10.1016/S0140-6736(25)00778-0
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
